Public Meeting of the Presidential Commission for the Study of Bioethical Issues, 26963-26964 [2014-10761]
Download as PDF
<![CDATA[
26963
Federal Register / Vol. 79, No. 91 / Monday, May 12, 2014 / Notices
Federal Communications Commission.
Marlene H. Dortch,
Secretary, Office of the Secretary, Office of
Managing Director.
[FR Doc. 2014–10821 Filed 5–9–14; 8:45 am]
BILLING CODE 6712–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
[Document Identifier: HHS–OS–0945–New–
30D]
Agency Information Collection
Activities; Submission to OMB for
Review and Approval; Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, has submitted an
Information Collection Request (ICR),
described below, to the Office of
Management and Budget (OMB) for
review and approval. The ICR is for a
new collection. Comments submitted
during the first public review of this ICR
will be provided to OMB. OMB will
accept further comments from the
SUMMARY:
public on this ICR during the review
and approval period.
DATES: Comments on the ICR must be
received on or before June 11, 2014.
ADDRESSES: Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Information Collection Clearance staff,
Information.CollectionClearance@
hhs.gov or (202) 690–6162.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
Information Collection Request Title
and document identifier HHS–OS–
0945–New–30D for reference.
Information Collection Request Title:
HIPAA Covered Entity and Business
Associate Pre-Audit Survey
Abstract: This information collection
consists of a survey of up to 1200 Health
Insurance Portability and
Accountability Act of 1996 (HIPAA)
covered entities (health plans, health
care clearinghouses, and certain health
care providers) and business associates
(entities that provider certain services to
a HIPAA covered entity) to determine
suitability for the Office for Civil Rights
(OCR) HIPAA Audit Program. The
survey will gather information about
respondents to enable OCR to assess the
size, complexity, and fitness of a
respondent for an audit. Information
collected includes, among other things,
recent data about the number of patient
visits or insured lives, use of electronic
information, revenue, and business
locations.
Need and Proposed Use of the
Information: The Office for Civil Rights
(OCR) is mandated to conduct periodic
audits to assess the compliance of
covered entities and business associates
with the HIPAA Privacy, Security, and
Breach Notification Rules. This
information collection will enable OCR
to assess the suitability of respondent
covered entities and business associates
for audits.
Likely Respondents: Respondents will
include both HIPAA covered entities
and business associates.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions, to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information, to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information, and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Average
burden per
response
(in hours)
Type of
respondent
OCR Pre-Audit Survey ......................
OCR Pre-Audit Survey ......................
Covered Entity ..................................
Business Associate ..........................
800
400
1
1
30/60
30/60
400
200
Total ...........................................
...........................................................
1200
1
30/60
600
Darius Taylor,
Information Collection Clearance Officer.
ACTION:
[FR Doc. 2014–10829 Filed 5–9–14; 8:45 am]
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Public Meeting of the Presidential
Commission for the Study of
Bioethical Issues
VerDate Mar<15>2010
18:00 May 09, 2014
Jkt 232001
The meeting will take place
Monday, June 9, 2014, from 9 a.m. to
approximately 5 p.m. and Tuesday, June
10, 2014, from 9 a.m. to approximately
1 p.m.
DATES:
Office of the Secretary, Office
of the Assistant Secretary for Health,
Presidential Commission for the Study
of Bioethical Issues, Department of
Health and Human Services.
AGENCY:
Notice of meeting.
The Presidential Commission
for the Study of Bioethical Issues (the
Commission) will conduct its
seventeenth meeting on June 9–10,
2014. At this meeting, the Commission
will discuss the BRAIN Initiative and
ongoing work in neuroscience.
BILLING CODE 4153–01–P
emcdonald on DSK67QTVN1PROD with NOTICES
Number of
respondents
Number of
responses per
respondent
Form name
The Lawrence P. and Ann
Estes Klamon Room, Rollins School of
Public Health, Emory University,
ADDRESSES:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
Total burden
hours
Claudia Nance Rollins Building, 1518
Clifton Road NE., Atlanta, GA 30322.
FOR FURTHER INFORMATION CONTACT:
Hillary Wicai Viers, Communications
Director, Presidential Commission for
the Study of Bioethical Issues, 1425
New York Avenue NW., Suite C–100,
Washington, DC 20005. Telephone:
202–233–3960. Email: Hillary.Viers@
bioethics.gov. Additional information
may be obtained at www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to the Federal Advisory Committee Act
of 1972, Public Law 92–463, 5 U.S.C.
app. 2, notice is hereby given of the
seventeenth meeting of the Commission.
The meeting will be open to the public
with attendance limited to space
E:\FR\FM\12MYN1.SGM
12MYN1
emcdonald on DSK67QTVN1PROD with NOTICES
26964
Federal Register / Vol. 79, No. 91 / Monday, May 12, 2014 / Notices
available. The meeting will also be
webcast at www.bioethics.gov.
Under authority of Executive Order
13521, dated November 24, 2009, the
President established the Commission.
The Commission is an expert panel of
not more than 13 members who are
drawn from the fields of bioethics,
science, medicine, technology,
engineering, law, philosophy, theology,
or other areas of the humanities or
social sciences. The Commission
advises the President on bioethical
issues arising from advances in
biomedicine and related areas of science
and technology. The Commission seeks
to identify and promote policies and
practices that ensure scientific research,
health care delivery, and technological
innovation are conducted in a socially
and ethically responsible manner.
The main agenda item for the
Commission’s seventeenth meeting is to
discuss the BRAIN Initiative and
ongoing work in neuroscience.
The draft meeting agenda and other
information about the Commission,
including information about access to
the webcast, will be available at
www.bioethics.gov.
The Commission welcomes input
from anyone wishing to provide public
comment on any issue before it.
Respectful debate of opposing views
and active participation by citizens in
public exchange of ideas enhances
overall public understanding of the
issues at hand and conclusions reached
by the Commission. The Commission is
particularly interested in receiving
comments and questions during the
meeting that are responsive to specific
sessions. Written comments will be
accepted at the registration desk and
comment forms will be provided to
members of the public in order to write
down questions and comments for the
Commission as they arise. To
accommodate as many individuals as
possible, the time for each question or
comment may be limited. If the number
of individuals wishing to pose a
question or make a comment is greater
than can reasonably be accommodated
during the scheduled meeting, the
Commission may make a random
selection.
Written comments will also be
accepted in advance of the meeting and
are especially welcome. Please address
written comments by email to info@
bioethics.gov, or by mail to the
following address: Public Commentary,
Presidential Commission for the Study
of Bioethical Issues, 1425 New York
Avenue NW., Suite C–100, Washington,
DC 20005. Comments will be publicly
available, including any personally
identifiable or confidential business
VerDate Mar<15>2010
18:00 May 09, 2014
Jkt 232001
information that they contain. Trade
secrets should not be submitted.
Anyone planning to attend the
meeting who needs special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify Esther Yoo by telephone
at (202) 233–3960, or email at
Esther.Yoo@bioethics.gov in advance of
the meeting. The Commission will make
every effort to accommodate persons
who need special assistance.
Dated: April 29, 2014.
Lisa M. Lee,
Executive Director, Presidential Commission
for the Study of Bioethical Issues.
[FR Doc. 2014–10761 Filed 5–9–14; 8:45 am]
BILLING CODE 4154–06–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
AGENCY:
ACTION:
Notice.
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project:
‘‘Updating and Expanding the AHRQ QI
Toolkit for Hospitals.’’ In accordance
with the Paperwork Reduction Act of
1995, Public Law 104–13 (44 U.S.C.
3506(c)(2)(A)), AHRQ invites the public
to comment on this proposed
information collection.
SUMMARY:
Comments on this notice must be
received by July 11, 2014.
DATES:
Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by
email at doris.lefkowitz@ahrq.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Proposed Project
Updating and Expanding the AHRQ QI
Toolkit for Hospitals
AHRQ has developed sets of Quality
Indicators (QIs) that can be used to
document quality and safety conditions
at U.S. hospitals. Three sets of QIs are
particularly relevant for hospitals and
include: The Inpatient Quality
Indicators (IQIs), the Patient Safety
Indicators (PSIs), and the Pediatric
Quality Indicators (PDIs). The IQIs
contain measures of volume, mortality,
and utilization for common medical
conditions and major surgical
procedures. The PSIs are a set of
measures to screen for potentially
preventable adverse events that patients
may experience during hospitalization.
The PDIs measure the quality of
pediatric health care, mainly focusing
on preventable complications that occur
as a consequence of hospitalization
among pediatric patients. These QIs
have been previously developed and
evaluated by AHRQ, and are in use at
a number of hospitals throughout the
country. The QIs and supportive
documentation on how to work with
them are posted on AHRQ’s Web site at
www.qualityindicators.ahrq.gov.
Despite the availability of the QIs as
tools to help hospitals assess their
performance, many U.S. hospitals have
limited experience with the use of such
measurement tools, or in using quality
improvement methods to improve their
performance as assessed by these
measures. To this end, RAND has
previously contracted with AHRQ to
develop an AHRQ Quality Indicators
Toolkit for Hospitals (Toolkit). This
Toolkit is publicly available and is
posted on AHRQ’s Web site at https://
www.ahrq.gov/professionals/systems/
hospital/qitoolkit/. The
Toolkit assists hospitals in both using
the QIs and improving the quality and
safety of the care they provide, as
measured by those indicators. As such,
the Toolkit includes: (1) Instruction on
how a hospital can apply the QIs to its
inpatient data to estimate rates for each
indicator; (2) methods the hospital can
use to evaluate these QI rates for
identifying opportunities for
improvement; (3) strategies for
implementing interventions (or
evidence-based best practices); (4)
methods to measure progress and
performance on the QIs; (5) tools for
evaluating the cost-effectiveness of these
changes; and (6) discussion of the value
of using the QIs for quality
improvement as well as potential
challenges and barriers to quality
improvement efforts that incorporate the
QIs and how to help overcome them.
E:\FR\FM\12MYN1.SGM
12MYN1
]]>Agencies
[Federal Register Volume 79, Number 91 (Monday, May 12, 2014)]
[Notices]
[Pages 26963-26964]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-10761]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Meeting of the Presidential Commission for the Study of
Bioethical Issues
AGENCY: Office of the Secretary, Office of the Assistant Secretary for
Health, Presidential Commission for the Study of Bioethical Issues,
Department of Health and Human Services.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Presidential Commission for the Study of Bioethical Issues
(the Commission) will conduct its seventeenth meeting on June 9-10,
2014. At this meeting, the Commission will discuss the BRAIN Initiative
and ongoing work in neuroscience.
DATES: The meeting will take place Monday, June 9, 2014, from 9 a.m. to
approximately 5 p.m. and Tuesday, June 10, 2014, from 9 a.m. to
approximately 1 p.m.
ADDRESSES: The Lawrence P. and Ann Estes Klamon Room, Rollins School of
Public Health, Emory University, Claudia Nance Rollins Building, 1518
Clifton Road NE., Atlanta, GA 30322.
FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications
Director, Presidential Commission for the Study of Bioethical Issues,
1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Telephone:
202-233-3960. Email: Hillary.Viers@bioethics.gov. Additional
information may be obtained at www.bioethics.gov.
SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given
of the seventeenth meeting of the Commission. The meeting will be open
to the public with attendance limited to space
[[Page 26964]]
available. The meeting will also be webcast at www.bioethics.gov.
Under authority of Executive Order 13521, dated November 24, 2009,
the President established the Commission. The Commission is an expert
panel of not more than 13 members who are drawn from the fields of
bioethics, science, medicine, technology, engineering, law, philosophy,
theology, or other areas of the humanities or social sciences. The
Commission advises the President on bioethical issues arising from
advances in biomedicine and related areas of science and technology.
The Commission seeks to identify and promote policies and practices
that ensure scientific research, health care delivery, and
technological innovation are conducted in a socially and ethically
responsible manner.
The main agenda item for the Commission's seventeenth meeting is to
discuss the BRAIN Initiative and ongoing work in neuroscience.
The draft meeting agenda and other information about the
Commission, including information about access to the webcast, will be
available at www.bioethics.gov.
The Commission welcomes input from anyone wishing to provide public
comment on any issue before it. Respectful debate of opposing views and
active participation by citizens in public exchange of ideas enhances
overall public understanding of the issues at hand and conclusions
reached by the Commission. The Commission is particularly interested in
receiving comments and questions during the meeting that are responsive
to specific sessions. Written comments will be accepted at the
registration desk and comment forms will be provided to members of the
public in order to write down questions and comments for the Commission
as they arise. To accommodate as many individuals as possible, the time
for each question or comment may be limited. If the number of
individuals wishing to pose a question or make a comment is greater
than can reasonably be accommodated during the scheduled meeting, the
Commission may make a random selection.
Written comments will also be accepted in advance of the meeting
and are especially welcome. Please address written comments by email to
info@bioethics.gov, or by mail to the following address: Public
Commentary, Presidential Commission for the Study of Bioethical Issues,
1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Comments
will be publicly available, including any personally identifiable or
confidential business information that they contain. Trade secrets
should not be submitted.
Anyone planning to attend the meeting who needs special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify Esther Yoo by telephone at (202) 233-
3960, or email at Esther.Yoo@bioethics.gov in advance of the meeting.
The Commission will make every effort to accommodate persons who need
special assistance.
Dated: April 29, 2014.
Lisa M. Lee,
Executive Director, Presidential Commission for the Study of Bioethical
Issues.
[FR Doc. 2014-10761 Filed 5-9-14; 8:45 am]
BILLING CODE 4154-06-P
